ARTICLE | Company News
Management tracks
May 5, 2015 1:09 AM UTC
Metabolic play Intarcia Therapeutics Inc. (Boston, Mass.) named Michael Williams COO. Williams was head of global marketing at the Tokyo division of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502).
Neurology play Impax Laboratories Inc. (NASDAQ:IPXL) named Deborah Penza SVP and chief compliance officer. Penza was chief compliance officer at Actavis plc (NYSE:ACT). ...